108 related articles for article (PubMed ID: 2068275)
21. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
22. The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids.
Gedda L; Ghaneolhosseini H; Nilsson P; Nyholm K; Pettersson J; Sjöberg S; Carlsson J
Anticancer Drug Des; 2000 Aug; 15(4):277-86. PubMed ID: 11200503
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro.
Brown DM; Gonzalez-Mendez R; Brown JM
Radiat Res; 1983 Mar; 93(3):492-505. PubMed ID: 6856754
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
[TBL] [Abstract][Full Text] [Related]
26. Action of misonidazole on L5178Y-R and L5178Y-S cells. II. Cytotoxicity and radiosensitization under hypoxic conditions.
Niepokojczycka E; Szumiel I; Walicka M
Neoplasma; 1981; 28(4):435-40. PubMed ID: 7290267
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
28. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
29. Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids.
Bajaj NP; McLean MJ; Waring MJ; Smekal E
J Mol Recognit; 1990 Feb; 3(1):48-54. PubMed ID: 2354064
[TBL] [Abstract][Full Text] [Related]
30. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
[TBL] [Abstract][Full Text] [Related]
31. Iodinated nitroimidazoles as radiosensitizers.
Krause W; Jordan A; Scholz R; Jimenez JL
Anticancer Res; 2005; 25(3B):2145-51. PubMed ID: 16158957
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
33. Aerobic and hypoxic toxicity of a new class of mixed-function drugs associating nitroimidazoles and chloroethylnitrosourea in nitrosourea-sensitive (Mer-) and -resistant (Mer+) human tumor cells.
Mulcahy RT; Carminati A; Barascut JL; Imbach JL
Cancer Res; 1988 Feb; 48(4):798-801. PubMed ID: 3338077
[TBL] [Abstract][Full Text] [Related]
34. Metabolic potentiation of the radiosensitization of hypoxic bacterial cells afforded by nitroaromatic compounds.
Anderson RF; Patel KB
Radiat Res; 1983 Mar; 93(3):516-24. PubMed ID: 6344127
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
Taylor YC; Brown JM
Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic radiosensitizers: prospects for effective compounds with fewer toxic side-effects.
Rupp WD; Mroczkowski Z; Agrawal KC
Br J Cancer Suppl; 1978 Jun; 3():60-3. PubMed ID: 98175
[TBL] [Abstract][Full Text] [Related]
37. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
Magdon E; Schröder E
Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitizers: rationale and potential.
Brown JM
Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
[TBL] [Abstract][Full Text] [Related]
39. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
[TBL] [Abstract][Full Text] [Related]
40. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
Takanuki K; Igarashi T; Hata K; Hori H; Shibata T; Kitagawa H; Satoh T; Inayama S
Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
